Ledipasvir/Sofosbuvir plus /-Ribavirin in HCV Post-Transplant Patients: Real-World Heterogeneous Population from the TRIO Network

被引：0

作者：

Curry, Michael P. ^{[1
]}

Bacon, Bruce ^{[2
]}

Dieterich, Douglas T. ^{[3
]}

Guest, Lauren ^{[4
]}

Kowdley, Kris ^{[5
]}

Lee, Yoori ^{[4
]}

Tsai, Naoky ^{[6
]}

Younossi, Zobair ^{[7
]}

Flamm, Steven L. ^{[8
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Med, Boston, MA 02215 USA

[2] St Louis Univ, Sch Med, Med, St Louis, MO USA

[3] Icahn Sch Med Mt Sinai, Med, New York, NY 10029 USA

[4] Trio Hlth Analyt, La Jolla, CA USA

[5] Swedish Med Ctr, Med, Seattle, WA USA

[6] Univ Hawaii, Queens Med Ctr, Med, Honolulu, HI 96822 USA

[7] Inova Fairfax Hosp, Med, Falls Church, VA USA

[8] Northwestern Univ, Feinberg Sch Med, Med, Chicago, IL 60611 USA

来源：

TRANSPLANTATION | 2016年 / 100卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

O-36

引用

页码：S91 / S91

页数：1

共 50 条

[31] A real-world study of treating advanced liver cirrhosis due to chronic HCV infection genotype 1b with sofosbuvir plus ledipasvir with or without ribavirin: results from a cohort of 349 patients [J].

Preda, Carmen Monica ;

Gheorghe, Liana ;

Istratescu, Doina ;

Manuc, Mircea ;

Pop, Corina ;

Andreea, Grigore ;

Iacob, Speranta ;

Manuc, Teodora ;

Tugui, Letita ;

Tieranu, Cristian ;

Diculescu, Mircea Mihai ;

Iliescu, Elena Laura .

JOURNAL OF HEPATOLOGY, 2020, 73 :S334-S334

[32] The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data [J].

Pyrsopoulos, Nikolaos ;

Trilianos, Panagiotis ;

Lingiah, Vivek A. ;

Fung, Phoenix ;

Punnoose, Merlin .

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (07) :761-765

[33] Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective? [J].

Demirturk, Nese ;

Aygen, Bilgehan ;

Celik, Ilhami ;

Mistik, Resit ;

Akhan, Sila ;

Barut, Sener ;

Ural, Onur ;

Batirel, Ayse ;

Simsek, Funda ;

Ersoz, Gulden ;

Inan, Dilara ;

Kinikli, Sami ;

Turker, Nesrin ;

Bilgin, Huseyin ;

Gurbuz, Yunus ;

Tulek, Necla ;

Tarakci, Huseyin ;

Yildiz, Orhan ;

Turkoglu, Emine ;

Guzel, Deniz Kamalak ;

Simsek, Sumeyra ;

Tuna, Nazan ;

Demir, Nazlim Aktug ;

Cagatay, Atahan ;

Cetinkaya, Riza Aytac ;

Karakecili, Faruk ;

Hakyemez, Ismail Necati ;

Ertem, Gunay Tuncer ;

Ormen, Bahar ;

Korkmaz, Pinar ;

Sili, Uluhan ;

Kuruuzum, Ziya ;

Sener, Alper ;

Ozel, Selcan Arslan ;

Ozturk, Sinan ;

Suer, Kaya ;

Celen, Mustafa Kemal ;

Konya, Petek ;

Asan, Ali ;

Saltoglu, Nese ;

Dogan, Nurhan .

TURKISH JOURNAL OF GASTROENTEROLOGY, 2021, 32 (02) :155-163

[34] Real World Outcomes of DAA Therapy With Sofosbuvir and Daclatasvir plus Ribavirin in HCV GT 3 Patients in Pakistan [J].

Choudhry, Asad ;

Tariq, Umer ;

Khalid, Ayesha ;

Arif, Rabeeya ;

Choudhry, Arham ;

Ali, Bushra ;

Nawaz, Arif ;

Nawaz, Hesham .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 :S531-S532

[35] The real-world safety and efficacy of sofosbuvir plus ribavirin for eldery patients over 75 years of age [J].

Tamai, H. ;

Shingaki, N. ;

Ida, Y. ;

Shimizu, R. ;

Maeshima, S. ;

Okamura, J. ;

Kawashima, A. ;

Nakao, T. ;

Hara, T. .

JOURNAL OF HEPATOLOGY, 2018, 68 :S284-S284

[36] The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir [J].

Walker, David R. ;

Juday, Timothy R. ;

Manthena, Shivaji R. ;

Jing, Yonghua ;

Sood, Vipan .

CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 :637-642

[37] ACCESS TO HCV CARE IN THE UNITED STATES: REAL-WORLD EXPERIENCE FROM THE TRIO NETWORK [J].

Younossi, Zobair M. ;

Bacon, Bruce ;

Curry, Michael ;

Dieterich, Douglas T. ;

Flamm, Steven L. ;

Kowdley, Kris V. ;

Milligan, Scott ;

Tsai, Naoky ;

Afdhal, Nezam H. .

GASTROENTEROLOGY, 2017, 152 (05) :S1089-S1090

[38] Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan [J].

Liu, Chen-Hua ;

Liu, Chun-Jen ;

Su, Tung-Hung ;

Yang, Hung-Chih ;

Hong, Chun-Ming ;

Tseng, Tai-Chung ;

Chen, Pei-Jer ;

Chen, Ding-Shinn ;

Kao, Jia-Horng .

PLOS ONE, 2018, 13 (12)

[39] Ledipasvir/Sofosbuvir plus Ribavirin (LDV/SOF+RBV) for 12 Weeks in Decompensated HCV Genotype 1 Patients: SOLAR-1 and-2 Studies Compared to a Real-World Dataset [J].

Charlton, Michael R. ;

Cheung, Michelle C. ;

Manns, Michael P. ;

Sajed, Nika ;

Troke, Philip ;

Spellman, James G. ;

Copans, Amanda ;

Arterburn, Sarah ;

Brainard, Diana M. ;

Irving, William ;

Foster, Graham R. .

HEPATOLOGY, 2016, 64 :489A-490A

[40] Treatment of Hepatitis C with ledipasvir, sofosbuvir with or without ribavirin in post liver transplant patients in an academic center [J].

Pyrsopoulos, Nikolaos ;

Lingiah, Vivek A. ;

Sanaka, Sirish ;

Fung, Phoenix ;

Punnoose, Merlin .

HEPATOLOGY, 2016, 64 :810A-810A

← 1 2 3 4 5 →